Cholesterol reduction by immunization with a PCSK9 mimic

Baoshan Zhang,Gwo-Yu Chuang,Andrea Biju,Daniel Biner,Jiaxuan Cheng,Yiran Wang,Saran Bao,Cara W. Chao,Haotian Lei,Tracy Liu,Alexandra F. Nazzari,Yongping Yang,Tongqing Zhou,Steven J. Chen,Xuejun Chen,Wing-Pui Kong,Li Ou,Danealle K. Parchment,Edward K. Sarfo,HaoMin SiMa,John-Paul Todd,Shuishu Wang,Ruth A. Woodward,Cheng Cheng,Reda Rawi,John R. Mascola,Peter D. Kwong
DOI: https://doi.org/10.1016/j.celrep.2024.114285
IF: 8.8
2024-05-31
Cell Reports
Abstract:Proprotein convertase subtilisin/kexin type 9 (PCSK9) controls cholesterol homeostasis. To assess the feasibility of a PCSK9-based heart attack vaccine, Zhang et al. create a PCSK9 mimic and demonstrate in mice and NHPs its ability to significantly reduce cholesterol. Unexpectedly, the vaccine-induced antibodies also altered the PCSK9 half-life, blunting vaccine impact.
cell biology
What problem does this paper attempt to address?